239 related articles for article (PubMed ID: 30641523)
21. Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.
Adam MA; Untch BR; Olson JA
Oncologist; 2010; 15(1):61-72. PubMed ID: 20051478
[TBL] [Abstract][Full Text] [Related]
22. [CDC73 gene mutation and parafibromin expression status of parathyroid carcinoma in Chinese].
Kong J; Wang O; Nie M; Shi J; Jiang Y; Li M; Xia WB; Meng XW; Xing XP
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3364-8. PubMed ID: 24418033
[TBL] [Abstract][Full Text] [Related]
23. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic-therapeutic management of parathyroid carcinoma].
Sillero Sánchez A; Atienza Iglesias MA
An Med Interna; 2002 Dec; 19(12):644-8. PubMed ID: 12593036
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
Ozolins A; Narbuts Z; Vanags A; Simtniece Z; Visnevska Z; Akca A; Wirowski D; Gardovskis J; Strumfa I; Goretzki PE
Langenbecks Arch Surg; 2016 Nov; 401(7):943-951. PubMed ID: 26658808
[TBL] [Abstract][Full Text] [Related]
26. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.
Obara T; Fujimoto Y
World J Surg; 1991; 15(6):738-44. PubMed ID: 1767540
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid cancer: etiology, clinical presentation and treatment.
Lumachi F; Basso SM; Basso U
Anticancer Res; 2006; 26(6C):4803-7. PubMed ID: 17214344
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid carcinoma.
Mittendorf EA; McHenry CR
J Surg Oncol; 2005 Mar; 89(3):136-42. PubMed ID: 15719375
[TBL] [Abstract][Full Text] [Related]
31. Functioning parathyroid carcinoma: clinicopathologic features and rational treatment.
Obara T; Okamoto T; Kanbe M; Iihara M
Semin Surg Oncol; 1997; 13(2):134-41. PubMed ID: 9088069
[TBL] [Abstract][Full Text] [Related]
32. Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome.
Mamedova E; Mokrysheva N; Vasilyev E; Petrov V; Pigarova E; Kuznetsov S; Kuznetsov N; Rozhinskaya L; Melnichenko G; Dedov I; Tiulpakov A
Endocr Connect; 2017 Nov; 6(8):557-565. PubMed ID: 28870973
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review.
Roser P; Leca BM; Coelho C; Schulte KM; Gilbert J; Drakou EE; Kosmas C; Ling Chuah L; Wassati H; Miras AD; Crane J; Aylwin SJB; Grossman AB; Dimitriadis GK
Endocr Relat Cancer; 2023 Apr; 30(4):. PubMed ID: 36621911
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid carcinoma.
Rodgers SE; Perrier ND
Curr Opin Oncol; 2006 Jan; 18(1):16-22. PubMed ID: 16357559
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
Howell VM; Gill A; Clarkson A; Nelson AE; Dunne R; Delbridge LW; Robinson BG; Teh BT; Gimm O; Marsh DJ
J Clin Endocrinol Metab; 2009 Feb; 94(2):434-41. PubMed ID: 19017757
[TBL] [Abstract][Full Text] [Related]
36. Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism.
Karakas E; Müller HH; Lyadov VK; Luz S; Schneider R; Rothmund M; Bartsch DK; Schlosser K
World J Surg; 2012 Nov; 36(11):2605-11. PubMed ID: 22777415
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
38. Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature.
Dutta A; Pal R; Jain N; Dutta P; Rai A; Bhansali A; Behera A; Saikia UN; Vishwajeet V; Collier D; Boon H; Korbonits M; Bhadada SK
J Endocr Soc; 2019 Dec; 3(12):2224-2235. PubMed ID: 31723720
[TBL] [Abstract][Full Text] [Related]
39. Genetic profiling as a clinical tool in advanced parathyroid carcinoma.
Kutahyalioglu M; Nguyen HT; Kwatampora L; Clarke C; Silva A; Ibrahim E; Waguespack SG; Cabanillas ME; Jimenez C; Hu MI; Sherman SI; Kopetz S; Broaddus R; Dadu R; Wanland K; Williams M; Zafereo M; Perrier N; Busaidy NL
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1977-1986. PubMed ID: 31309300
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of parafibromin staining and CDC73 mutation in patients with parathyroid carcinoma: A systematic review and meta-analysis based on individual patient data.
Zhu R; Wang Z; Hu Y
Clin Endocrinol (Oxf); 2020 Apr; 92(4):295-302. PubMed ID: 31945198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
